Lapatinib+Vinorelbine vs Vinorelbine HER2 Positive Metastatic Breast Cancer Progressed After Lapatinib/Trastuzumab
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: Lapatinib|DRUG: Vinorelbine
Sponsor: National Cancer Center, Korea
Collaborators: Asan Medical Center|Chung-Ang University|Korea University Anam Hospital|Samsung Medical Center|Seoul National University Hospital|Seoul National University Bundang Hospital